Are Analysts Growing Too Optimistic on Salesforce After Earnings?
Salesforce.com reported its most recent quarterly results after the markets closed on Tuesday. While results were incredibly positive, analysts juiced this stock and now it is going parabolic.
Salesforce.com Inc. (NYSE: CRM | CRM Price Prediction) reported its most recent quarterly results after the markets closed on Tuesday. While results were incredibly positive, analysts juiced this stock and now it is going parabolic.
24/7 Wall St. has included some highlights from the earnings report, as well as what analysts are saying about Salesforce after the fact.
The firm said that it had $1.44 in earnings per share (EPS) and $5.15 billion in revenue, versus consensus estimates that called for $0.67 in EPS and $4.9 billion in revenue. The same period of last year reportedly had $0.66 in EPS and $4.00 billion in revenue.
Subscription and support revenues for the quarter were $4.84 billion, an increase of 29% year over year. Professional services and other revenues for the quarter were $0.31 billion, an increase of 23%.
Looking ahead to the fiscal third quarter, the company is calling for EPS in the range of $0.73 to $0.74 and revenue between $5.24 billion and $5.25 billion. The consensus estimates are $0.83 in EPS and $5.28 billion in revenue for the quarter.
Here’s what analysts had to say:
- Morgan Stanley reiterated an Overweight rating and raised its price target to $275 from $195.
- Cowen reiterated an Outperform rating and raised its price target to $270 from $210.
- Truist reiterated a Buy rating and raised its price target to $287 from $210.
- Monness Crespi & Hardt reiterated a Buy rating and raised its price target to $275 from $195.
- Loop Capital reiterated a Sell rating and raised its price target to $160 from $150.
- Oppenheimer reiterated an Outperform rating and raised its price target to $265 from $205.
- Canaccord Genuity reiterated a Buy rating and raised its price target to $270 from $200.
- Citigroup reiterated a Buy rating and raised its price target to $300 from $196.
- Wedbush reiterated an Outperform rating and raised its price target to $300 from $250.
- Raymond James reiterated a Strong Buy rating and raised its price target to $255 from $230.
- Stifel reiterated a Buy rating and raised its price target to $295 from $220.
- Mizuho reiterated a Buy rating and raised its price target to $275 from $230.
- RBC reiterated an Outperform rating and raised its price target to $275 from $220.
- Piper Sandler reiterated an Overweight rating and raised its price target to $285 from $210.
- Credit Suisse reiterated an Outperform rating and raised its price target to $245 from $200.
- Goldman Sachs reiterated a Buy rating and raised its price target to $252 from $220.
- JPMorgan reiterated a Buy rating and raised its price target to $250 from $200.
Salesforce stock traded up about 27% on Wednesday, at $274.58 in a 52-week range of $115.29 to $277.95. The consensus price target is $220.17.
Contact [email protected] for any questions or corrections.
Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.
His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.
When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.
